Also trades as: MAYNF (OTC) · $vol 0M
MYX.AX ASX
Mayne Pharma Group Limited
1W: +1.4%
1M: -8.4%
3M: -1.0%
YTD: +0.3%
1Y: -45.1%
3Y: -19.0%
5Y: -52.3%
A$2.82 ($1.96)
-0.03 (-1.05%)
Weekly Expected Move ±5.6%
A$3
A$3
A$3
A$3
A$3
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#2
of 3
Medical - Pharmaceuticals
Technical Signal Map
1 Bullish
0 Neutral
2 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| MYX.AX Mayne Pharma Group Limited | $230M | 9.2 | -16.4 | -17.8 | 23.0 | 38.4 | 4 | BEARISH | -45.1 |
| BIO.AX Biome Australia Limited | $90M | 26.1 | 62.2 | 221.3 | 21.2 | 108.9 | 5 | BULLISH | -18.4 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $290M | — | — | — | — | — | — | BEARISH | — |
| MYX.AX Mayne Pharma Group Limited | $230M | 9.2 | -16.4 | -17.8 | 23.0 | 38.4 | 4 | BEARISH | -45.1 |
| BIO.AX Biome Australia Limited | $90M | 26.1 | 62.2 | 221.3 | 21.2 | 108.9 | 5 | BULLISH | -18.4 |
| CUVL Clinuvel Pharmaceuticals Ltd. | $290M | — | — | — | — | — | — | BEARISH | — |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
MYX.AX vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F